Crenolanib is a selective type I pan-FLT3 inhibitorCatherine C. Smith, Neil P. Shah, Elisabeth A. Lasater et al.|Proceedings of the National Academy of Sciences|2014Cited by 211
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemiaMayumi Sugita, Mónica L. Guzmán|npj Precision Oncology|2021Cited by 36
CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insightsNaveen Pemmaraju, Marina Konopleva, Mónica L. Guzmán et al.|Leukemia Research|2022Cited by 18